CroíValve
Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease
$27MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease
Develops a minimally invasive implantable device to treat benign prostatic hyperplasia in men
Develops orbital transport and re-entry vehicles
Develops innovative solutions for cardiology, specifically FlowMaker, a fully implantable cardiac...